DCN and chronic obstructive pulmonary disease: A trend for reduced expression of biglycan in parenchyma of patients with mild to moderate COPD compared to non-smokers and a significant reduction in decorin expression in parenchyma of patients with COPD in comparison with non-smokers has also been reported (Annoni et al., 2012).